Although, there is no evidence for a direct link between STAT3 activation and fibrosis in cancer models, it has been shown that pharmacological inhibition of STAT3 reduces and lowers the incidence of fibrotic tissue formation in a mouse model of colitis (56). This evidence concerns the gene STAT3 and colitis.